Sandoz Group Ltd (OTC:SDZXF) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Craig Marks | Investor Relations · Since at least Apr 2, 2026 |
| David Kamenir | Senior VP, Strategy and Growth, North America · Since at least Nov 5, 2026 |
| Elisa Fiorello | Senior VP, People & Organization · Since at least Nov 5, 2026 |
| Glenn Gerecke | President, Generics Manufacturing & Supply · Mar 10, 2026 – Nov 5, 2026 · Past |
| Jeff Borden | Senior VP, Supply Chain NA · Since at least Nov 5, 2026 |
| Jonathan Kimball | Senior VP, US and Global Public Affairs · Since at least Nov 5, 2026 |
| Katie Fischer | IR Coordinator · Since at least Apr 2, 2026 |
| Keren Haruvi | President North America · Since at least Aug 5, 2026 |
| Kristen Tilak | Senior VP and Chief Financial Officer, North America · Since at least Nov 5, 2026 |
| Len Arsenault | Senior VP, Scientific Affairs · Since at least Nov 5, 2026 |
| Leo Bronfman | Senior VP, General Counsel North America · Since at least Nov 5, 2026 |
| Martin Bick | Senior VP, Market Access, Specialty Contracting, & Patient Services · Since at least Nov 5, 2026 |
| Pascal Bouye | President, Generics Manufacturing & Supply · Since at least Jul 15, 2026 |
| Sébastien Ménard | Senior VP, Head of US Generics · Since at least Nov 5, 2026 |
| Shannon Buhl | Senior VP, Commercial Operations · Since at least Nov 5, 2026 |
| Silvia Siegfried | Senior Director, Investor Relations · Since at least Apr 2, 2026 |
| Tamara Hackl | Senior Director, Investor Relations · Since at least Apr 2, 2026 |
| Ted Stueck | Senior VP and Chief Ethics, Risk and Compliance Officer · Since at least Nov 5, 2026 |
| Tom Occhipinti | Senior VP, Head of US Biosimilar · Since at least Nov 5, 2026 |
| Yannis Skoufalos | Board member · Since at least Nov 5, 2026 |